Humira (Adalimumab) is a prescription medication approved by the FDA to treat adults with active ankylosing spondylitis. It is also indicated for treating uveitis, a type of eye inflammation that can develop in people with spondyloarthritis. Humira is an immunomodulator and a biologic disease-modifying antirheumatic drug read more

Humira (Adalimumab) is a prescription medication approved by the FDA to treat adults with active ankylosing spondylitis. It is also indicated for treating uveitis, a type of eye inflammation that can develop in people with spondyloarthritis. Humira is an immunomodulator and a biologic disease-modifying antirheumatic drug (DMARD). It works by inhibiting tumor necrosis factor alpha (TNF-α), a chemical messenger involved in autoimmune attacks.

Administration:
- After an initial loading dose, Humira is administered every other week by subcutaneous injection.
- It is available as a pen or prefilled syringe.

Common Side Effects:
- Respiratory infections
- Headache
- Redness or irritation at injection sites
- Rash

Rare but Serious Side Effects:
- Severe allergic reactions
- Potentially fatal infections
- Increased risk for developing certain types of cancer, such as lymphoma

For more details, you can visit the Humira page on MySpondylitisTeam: [Humira (Adalimumab) for Spondylitis](https://www.MySpondylitisTeam.com/treatments/hu...).

 This AI-generated response comes from MySpondylitisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Humira (Adalimumab) for Spondylitis | MySpondylitisTeam

Taking Biologics: Dosing, Insurance Coverage, and When You Can Stop (VIDEO) | MySpondylitisTeam